We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Falls More Steeply Than Broader Market: What Investors Need to Know
Read MoreHide Full Article
In the latest trading session, Albemarle (ALB - Free Report) closed at $108.25, marking a -4.6% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.03%. At the same time, the Dow lost 0.31%, and the tech-heavy Nasdaq gained 0.01%.
Coming into today, shares of the specialty chemicals company had lost 15.64% in the past month. In that same time, the Basic Materials sector lost 7.25%, while the S&P 500 gained 0.53%.
Analysts and investors alike will be keeping a close eye on the performance of Albemarle in its upcoming earnings disclosure. On that day, Albemarle is projected to report earnings of $2.55 per share, which would represent year-over-year growth of 1442.11%. In the meantime, our current consensus estimate forecasts the revenue to be $1.52 billion, indicating a 16.07% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of $11.39 per share and a revenue of $6.1 billion, demonstrating changes of +1541.77% and +18.69%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 2.05% downward. Albemarle is currently a Zacks Rank #4 (Sell).
In the context of valuation, Albemarle is at present trading with a Forward P/E ratio of 9.96. This denotes a discount relative to the industry average Forward P/E of 16.4.
It is also worth noting that ALB currently has a PEG ratio of 0.66. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Chemical - Diversified stocks are, on average, holding a PEG ratio of 1.2 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 161, finds itself in the bottom 35% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest trading session, Albemarle (ALB - Free Report) closed at $108.25, marking a -4.6% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.03%. At the same time, the Dow lost 0.31%, and the tech-heavy Nasdaq gained 0.01%.
Coming into today, shares of the specialty chemicals company had lost 15.64% in the past month. In that same time, the Basic Materials sector lost 7.25%, while the S&P 500 gained 0.53%.
Analysts and investors alike will be keeping a close eye on the performance of Albemarle in its upcoming earnings disclosure. On that day, Albemarle is projected to report earnings of $2.55 per share, which would represent year-over-year growth of 1442.11%. In the meantime, our current consensus estimate forecasts the revenue to be $1.52 billion, indicating a 16.07% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of $11.39 per share and a revenue of $6.1 billion, demonstrating changes of +1541.77% and +18.69%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Albemarle. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 2.05% downward. Albemarle is currently a Zacks Rank #4 (Sell).
In the context of valuation, Albemarle is at present trading with a Forward P/E ratio of 9.96. This denotes a discount relative to the industry average Forward P/E of 16.4.
It is also worth noting that ALB currently has a PEG ratio of 0.66. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. Chemical - Diversified stocks are, on average, holding a PEG ratio of 1.2 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 161, finds itself in the bottom 35% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.